Isomorphic LabsAn AI-driven drug discovery company leveraging AlphaFold to accelerate therapeutic development.

Isomorphic Labs is a company that uses AI, specifically building on the AlphaFold system, to accelerate therapeutic development and ultimately solve all diseases. They leverage machine learning to transform drug discovery, with the goal of designing novel molecules, anticipating drug performance, and developing innovative medicines. The company is founded on the principle of harnessing the power of information science to model complex biological phenomena. This is done through the Isomorphism concept, which aims to uncover the underlying symmetry between biology and information science. By using AI to overcome the limitations of traditional discovery methods, Isomorphic Labs aims to improve human health. Their interdisciplinary team of experts in drug discovery and machine learning builds predictive and generative AI models. These tools enable digital biology, allowing for faster breakthroughs and life-changing medicines. The company is on a mission to advance human health through the application of frontier AI. Isomorphic Labs was founded by Sir Demis Hassabis, who believes that there is no more important application for AI than helping to improve human health. The company has received investments and entered into research collaborations, showing their commitment to the development of AI-powered drug discovery.